Mindfulness-Based Cognitive Behavior Therapy for Bipolar Disorder



Status:Archived
Conditions:Psychiatric, Bipolar Disorder
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:January 2010
End Date:April 2012

Use our guide to learn which trials are right for you!

Mindfulness-Based Cognitive Behavior Therapy for Bipolar Disorder: A Randomized, Controlled Study


The purpose of the study is to investigate the efficacy of mindfulness-based
cognitive-behavior therapy (MBCT) for improvement of symptoms associated with bipolar
disorder, by comparing MBCT to supportive psychotherapy. Patients who participate in this
study will be randomly assigned to receive either

1. state of the art group MBCT, or

2. supportive group psychotherapy (which is considered part of the standard care available
to patients at MGH).


We will conduct a randomized controlled trial of group MBCT (n=30) vs. SP (n=30) and compare
the benefits and durability of MBCT vs. SP for decreasing symptoms in DSM-IV bipolar
individuals over a 12-week period adjunctive to mood stabilizing medications coupled with
individual-therapy sessions. We will also conduct follow-up assessments at 3, 6, 9, and 12
months after the active phase of the study. Subjects in the MBCT group will receive group
therapy sessions of standardized yoga-meditation based exercises enhanced by psychoeducation
and relapse prevention for bipolar disorder. Subjects in the SP group will receive support
for coping with the symptoms of bipolar disorder, as well as psychoeducation about bipolar
disorder. The focus of SP is on reflecting and expressing feelings about current life
issues. Patients are supported and comforted when coping with difficult situations,
depression, mood swings, or anger. We will assess mood, cognitive and psychosocial
functioning before and after treatment for participants in both groups. Finally, we will
investigate the functional neuroanatomy associated with memory impairment, attention, and
mindful breathing in subjects with bipolar disorder as a predictor of treatment response
using functional Magnetic Resonance Imaging (fMRI).


We found this trial at
1
site
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
?
mi
from
Boston, MA
Click here to add this to my saved trials